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The non-mitogcnic stimulation of human peripheral blood mononuclear cells (PBMC) with low concentrations of the phorbol ester 17-0 
tctradecanoylphorbol 13.acetate (TPA) caused a progressive increase in the percent fraction of the cells that were positive for the early activating 
antigen CD69. At the same time, it caused aprogressive increase in the steady-state l vels of poly(ADP-ribose) polymerase (pADPRP) transcripts. 
A further increase in TPA concentration, while inducing the maximal expression of the levels ofCD69 activating surface antigen, both in the prcscncc 
or in the absence of proliferative activity, did not cvokc any additional hightening of pADPRP mRNA levels. Time course of PBMC stimulation 
with a non-mitogenic dose of TPA showed an early increase in the accumulation of pADPRP mRNA. which changed at g-16 h, and remained 
high for several days thcreufter. On the basis ofthesc data, we suggest that the increase in pADPRPmRNA may be associated with thccommitmcnt 
0r human lymphocytc3 rrom a quiescent (G,) to an activated (G,) state. 
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1, INTRODUCTlON 
Considerable interest has been focused on the dif- 
ferences between quiescent and activated or actively cy- 
cling cells and the processes responsible for the transi- 
tions between these various states [I]. As for lyrii- 
phocytes, these transitions can be triggered in vitro by 
lectins, by monoclonal antibodies to cell surface re- 
ceptors, and by phorbol esters, a known class of acti- 
vators of protein kinase C [2]. After stimulation of pro- 
liferatively resting (G, phase) lymphocytes, T cells enter 
the G, phase of the mitotic cell cycle, during which they 
become able to express newly synthesized antigens, such 
as the CD69 early activation antigen [3-4] and an inter- 
leukin-2 receptor (IL-2R). Thereafter, they start to 
produce interleukin 2 (IL-2), which then will bind to its 
own receptors to make possible the intra-cycle progres- 
sion of T cells leading to the G,-S transition [S]. 
Poly(APP-ribose) is synthesized from NAD+ inside 
the nuclei of eukaryotic ells by the enzyme poly(ADP- 
ribose) polymerase (EC 2.4.2.30), which is thought o be 
involved in eukaryotic differentiation and in mitogenic 
events including the activation of quiescent lym- 
phocytes [6]. Several reports have hitherto appeared, 
indicating that: (i) pADPRP activity increased with 
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DNA synthesis in phytohemagglutinin (PHA)-stimu- 
lated lymphocytes 16-71; (ii) mitogenic stimulation of 
purified T lymphocytes with the phorbol ester TPA and 
with a monoclonal antibody to the T3 cell surface anti- 
gen caused an increase in pADPRP activity [S]; and (iii) 
competitive inhibitors of pADPRP prevented the pro- 
liferation of PHA-stimulated T lymphocytes, whereas 
the stimulation of DNA synthesis by TPA was more 
resistant to the action of pADPRP inhibitors [9]. On the 
other hand, we recently observed that pADPRP steady 
state mRNA levels promptly increased starting 4 h after 
PHA stimulation of human T lymphocytes, remaining 
high until the end of the S phase of the cell cycle [lo]. 
In the present study, the expression of the pADPRP 
gene was studied during the activation of human peri- 
pheral blood mononuclear cells (PBMC) with TPA.This 
phorbol ester activated lymphocytes, by inducing the de 
novo synthesis and expression of nuclear proto-on- 
cogenes and surface activation antigens. However, dif- 
ferently from PHA, TPA itself did not induce a signifi- 
cant IL-2 production [1 11. Therefore, the mitogenic ac- 
tivity of TPA was much weaker than that of PHA. 
The aim of our work was to investigate whether the 
increase in pADPRP mRNA level is exclusively linked 
to stimuli, such as PI-IA, operating on the cell surface 
receptors, or may represent ageneral phenomenon that 
follows activation of lymphocytes by various agents. 
Moreover, we tried to understand whether non-mito- 
genie doses of TPA could increase pADPRP mRNA 
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levels or the phenomenon was only the consequence of
the full mitogenic response. 
2. MATERlALS AND METFIQDS 
Human PBMC were isolated from blood of normal donors by 
centrifugation on Ficoll-Hypaquc density gradients. Cells were cul- 
tured for different periods in macro wells at 2x 106/m1 in RPM1 1640 
medium containing 10% (v/v) fetal calf serum in the prcscncc of diffcr- 
cnt concentrations of TPA (Sigma) or PMA (Gibco, 1% v/v). 
PBMC, cultured for 24 h, were stained by indirect immunofluo- 
rescence using Cl, I i3 (antXD69) monoclonal antibody (mAb) [4] and 
tluoresccinated goat anti-mouse lg (Becton Dickinson). The back- 
ground fluorescence was assayed on cells stained with the Iluorcs- 
ceinated anti-mouse Ig reagent alone, Samples were analyzed with a 
flow cytomcter (Elite. Coulter. Hialeah, FL). 
2.3. Proli&utivo activity 
To cvaluatc the proliferative activity of PBMC after 3 days in 
culture, OS PCi of tritiated thymidine ([“H]TdR) was added 18 h 
before harvesting the cells and the macromolecular incorporation of 
this precursor was next measured by 3 liquid scintillation counter, 
Total cellular RNA was extracted from 10’ cells with guanidinium 
isothiocyanatc and purified by centrifugation through 5.7 M CsCl [ 12j. 
The RNA (20,~ per track) was then electrophorcsed on a 1% agarose 
denaturing el, transferred to a Hybond N membrane and hybridized 
to “P-labeled human pADPRP cDNA [I 31. 
1 
TPA Cngjml) 
Fig. 1. The expression of CD69 surface activating antigen in PBMC 
treated for 24 h with different concentrations of TPA. Each curve 
refers to data obtained in PBMC from a single donor. 
3. RESULTS 
As a first step, we analyzed the ability of different 
concentrations of TPA to increase pADPRP mRNA 
levels in relation both to PBMC activation and the pro- 
liferative response. 
In different individual donors, low doses of TPA, in 
the absence of other concomitant stimuli, induced the 
expression of the CD69 surface antigen in a dose-de- 
pendent fashion (Fig;. 1). PBMC activated for 24 11 by 
TPA (dose range, 0.5-1.2 ng/ml) showed increases in 
pADPRP mRNA levels (Fig. 2). In this experiment, it
Table I 
Effect of low concentrations ofTPA on the CD69 antigen expression and the proliferation of PBMC 
0 
TPA (ndml) PHA (1%) 
0.5 0.8 1.2 
CD69 antigen expression 
PHlTdR incorooration 
20( I.6)* 32( l-9) 67(2.2) 92(5.8) 78(3.5) 
300** 100 1,900 7,000 35,000 
‘The results, evaluated after 24 h ofculture, arc expressed as percentages ofCD69’ cells. The figures within brackets are mean lhtorescencc intensities 
of CD69’ CC& 
“The results (cpm), evaluated after 72 h of culture, are expressed 3s means from quadruplicate somples. 
Table II 
Effect of different concentrations of TPA on the CD69 antigen expression and the proliferation of PBMC 
TPA (ndml) PHA (1%) 
CD69 antigen expression 
[‘H]TdR incorporation 
0 1.2 1.6 2 5 
G(5.4)* 7G(26) 87(29) 87(30) 80(18) GT(13) 
2006. 2,500 3,000 3,360 2,500 49,ixGG 
‘The results, evaluated after 24 h ofculture, are expressed as percentage of CDG9+ cells. The figures within brackets are mean fluorescence intensities 
Of CD69’ C&i. 
“The results (cpm), evaluated after 72 h of cu!ture, arc cxpressltd as means From quadruplicatc samples. 
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Fig. 2. The steady-state mRNA levels for pADPRP gene in PBMC 
cultured with low concentrations of TPA. Tile mRNA level of 
pADPRP (3.8 kb) augments with the increase in conc ntration fTPA 
(0.5, 0.8. 1.2 ng/ml). The amount of ribosomal RNAs in the agarose 
gel quantified by ethidium bromide staining is shown in the lower part 
of the panel. The position of the ribosomal RNAs (28 S and 18 S) are 
indicated on the right. The dataconcerning.the expression of CD69 
surface activating antigen and the [SH]TdR incorporation for the same 
experiment are reported in Table I. 
appears that the increase of the level o f  pADPRP 
mRNA was accompanied by an enhanced expression of 
the CD69 antigen (Table I). Whereas, the increase in 
pADPRP mRNA was not linked to a significant pro- 
liferative activity (Table I). Concentrations of  TPA 
above 1.2 ng/ml, while providing the maximal level of  
CD69 antigen expression (Table II), did not produce a 
further increase of  the levels of pADPRP mRNA,  which 
was already and remained steadily high (Fig. 3). When 
TPA, at the highest concentrations used, acted as an 
effective mitogen, the pADPRP rnRNA levels were sim- 
ilar to those induced by the Go/G1 activating, yet non- 
mitogenic doses (data not shown). 
Figure 4 shows a time-course of  the steady-state ac- 
cumulation of pADPRP mRNA after the activation 
with a non-mitogenic dose of TPA (1.2 ng/ml). The 
increase in the accumulation of pADPRP transcript was 
detectable after 8-16 h exposure to the phorbol ester, 
and peaked at 48 h not declining appreciably until 4 
days had elapsed. Hence, the time course of  pADPRP 
mRNA accumulation was similar to that observed by 
us in T lymphoeytes [I0] and in PBMC (unpublished 
data) after stimulation with a mitogenie dose of PHA. 
28 S 
18S 
Fig. 3. The steady.state mRNA levels for pADPRP gene in PBMC 
cultured with different concentrations of TPA. The mRNA level of 
pADPRP (3.8 kb) does not augment with the increase in concentration 
of TPA (from 1.2 to 5 ng/ml). The amount of ribosomal RNAs in the 
agarose gel quantified by ¢thidium bromide staining is shown in the 
lower part of the panel. The position of the ribosomal RNAs (28 S and 
18 S) are indicated on the right. Tile data related to the expression of 
CD69 surface activating anti~,en a d the [~H]TdR incorporation for the 
same experiment arereported in Table 11.
PHA 1% 
h 0 8 16 24 48  72 ~ • 
Ot  
I 
~ 3 .8  kb  
288 
t8S  
Fig. 4. The time course of steady-state mRNA levels for pADPRP 
gene in PBMC cultured with a non-mitogenie dose o1" TPA. PBMC 
were cultured with 1.2ng:,/ml of TPA for different times (h). as indi- 
cated at tile top of the panel. PBMC were cultured with 1% of PHA 
for :)4 h as ~ positive control. The figure shows the mRNA level for 
the pADPRP gene (3.8 kb). The amount of the ribosomal RNAs in 
the agarose g l quantified by ethidium bromide staining s shown in 
the lower part of tile panel. The positions of ribosomal RNAs (28 S 
and 18 S) are indicated on the right. 
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4. DISCUSSION 
The study of the transition from the quiescent to the 
activated state of human lymphocytes and the iden- 
tillcation of the enzymes involved in these changes is 
interesting since the information thus obtained may 
help to find control points and clarify processes regulat- 
ing differentiation and/or prolifciation. 
In the present work the effects of TPA on PBMC 
differentiation and pADPRP gene expression were ex- 
amined. 
Several authors have claimed that pADPRP activity 
in lymphocytes increases 3-IO-fold over a period of 
X-7? h following the stimulation with PHA [6-i’]. This 
was recently confirmed by us in PBMC using activity gel 
methods [14]. We suggested that this amplified activity 
depended on the de novo enzyme synthesis, since a 
remarkable surge of the steady-state mRNA levels for 
pADPRP was shown to occur in purified T lymphocytes 
[IO] and in PBMC (unpublished ata) 4 h and 8 h, 
respectively, after PHA stimulation. 
King et al. [9] suggested that ADP-ribosylation plays 
a different role in the response of lymphocytes to vari- 
ous stimuli, because the proliferative response to TPA 
was found to be much less affected by pADPRP inhi- 
bitors than was that to PI-IA. We could not reject this 
suggestion, but we demonstrated that PBMC stimulated 
by PHA or TPA did not exhibit marked differences in 
the amounts or in the time courses of the transcript for 
the pADPRP gene. 
A previous report [S] showed that the increase in 
pADPRP activity occurred in association with the pro- 
liferative response in purified T-cell suspensions treated 
with TPA and the anti-T3 antibody. The two signals 
acted synergistically tostimulate the maximum increase 
in pADPRP activity. We used TPA alone to measure 
the level of pADPRP mRNA in activated, yet non- 
proliferating PBMC. In fact, in the majority of our 
experiments carried out with human PBMC, TPA was 
not mitogenic; nevertheless, the phorbol ester was found 
to induce the cell-surface xpression of the early activa- 
tion antigen CD69. In all experiments, lymphocyte 
activation by non-mitogenic doses of TPA was ac- 
companied by the induction of increased steady-state 
levels of pADPRP mRNA. Hence, we suggest that this 
increase in pADPRP mRNA is specifically associated 
with the transition from the quiescent o the activated 
state of human PBMC, i.e. with the commitment of such 
cells to grow, but not with their subsequent intra-cycle 
progression. In fact, when the mitogenic response oc- 
curred, no further increase in the steady-state pADPRP 
mRNA levels could be detected. ,This finding is in keep- 
ing with reports from several authors [15-171 which 
show oilat various competitive inhibitors of the cuc!ear 
enzyme pADPRP do block the differentiation of several 
62 
eukaryotic cell types without affecting their prolifera- 
tion, 
In conclusion, our data imply that the expression of 
the pADPRP gene is an early event, important for the 
response of PBMC to different stimuli, be they fully 
mitogenic (PHA) or simply activatory (TPA). There- 
fore, the observed increase in the mRNA levels for 
pAD?RP is no? in itself sufficient o cause the progres- 
sion through G, phase to DNA synthesis, an event pos- 
sibly modulated by other processes in human lym- 
phocytes. 
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